check insurance coverage for glp 1 Your one spot affordable GLP-1 pricing — with or without GLP-1 Cost Estimator Insurance and GLP-1s: How to

Although research on intranasal administration of BPC-157 is extremely limited, broad studies on the potential benefits of intranasally administered peptide therapeutics suggest that this may be a beneficial RoA [11, 12]

PMID: 21030672

For safety, healthcare providers advise avoiding supplements

Gastric electrical stimulation (the Enterra device) is FDA-approved under humanitarian device exemption but shows mixed results in clinical trials (McCallum et al., Gastroenterology, 2010)

It could be interesting to assess if overexpression of a molecule that inhibits microglia activation, such as CXCR1 or CD200R, can make donor microglia resistant to the degenerative environment in ALS